British PM Boris Johnson cancels trip to India over surge in COVID-19 cases
upi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upi.com Daily Mail and Mail on Sunday newspapers.
FDA inspecting Maryland Emergent plant after Johnson & Johnson COVID-19 vaccine mix-up
upi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upi.com Daily Mail and Mail on Sunday newspapers.
Merck ends studies for experimental drug to fight severe COVID-19
By (0)
Merck said, however, that it will continue trials for the oral antiviral drug molnupiravir, which it says shows promise as a potential treatment for milder cases of COVID-19. File Photo by Justin Lane/EPA-EFE
April 15 (UPI) Drugmaker Merck announced Thursday that it s ending clinical trials for an experimental COVID-19 drug after concluding that it didn t sufficiently help patients hospitalized with the virus.
The company had been examining the drug, called MK-7110, for its possible therapeutic effects on severe cases of COVID-19.
Advertisement
Merck said in a statement that the positive effects of the drug weren t sufficient to provide a meaningful measure of clinical effect.